Products
- Product Approval Information
- Product Labeling
- Product / Manufacturer Lists
- Adverse Event & Biological Product Deviation Reporting
- Blood Establishment Computer Software
- Compliance / Surveillance
- Donor Screening / HIV
- Export Certification
- Fast Track Performance Reports
- Product Deviation Reports
- Product Shortages
- Postmarket Commitments
- Recalls / Withdrawals / Field Corrections
- Safety Information
- User Fee Billable Products
- Violative Advertising & Promotional Labeling Letters
- Other Compliance Actions
- Transfer of Therapeutic Products to CDER
Industry
- Action Plans
- Adverse Event Reporting
- Code of Federal Regulations - Biologics Related
- Clinical Investigator Information
- Clinical Investigator Inspection List
- Combination Products
- Compliance / Surveillance
- Counterfeit Initiative
- Device Application Submission
- Electronic Submissions
- Export Certification
- Fast Track Performance Reports
- FAQs
- FDAMA (FDA Modernization Act)
- Guidances
- How to Submit an IND (Investigational New Drug Application)
- Electronic IND Demo
- MDUFMA (Medical Device User Fee & Modernization Act)
- Notice of Initiation of Disqualification Proceedings and Opportunity to Explain (NIDPOE) Letters
- PDMA (Prescription Drug Marketing Act)
- PDUFA (Prescription Drug User Fee Act)
- PHS Act - Licensing Biological Products
- User Fee Billable Products
- Product Shortages
- Postmarket Commitments
- Publications / Reading Room
- Small Business Information
- CBER SOPPS (Standard Operating Procedures and Policies)
Consumer / Healthcare Information
- Adverse Event Reporting
- Biological Product Deviation Reporting
- MedWatch
- Transfusion / Donation Related Fatalities
- Vaccine Adverse Event Reporting System
- All About Vaccines for Kids
- Clinical Investigator Information
- Compliance / Surveillance
- Counterfeit Initiative
- Countering Bioterrorism
- FDA Patient Safety News
- Frequently Asked Questions
- General
- Blood
- Vaccines
- Healthcare Letters
- Information Sheets
- Keeping Blood Transfusions Safe
- NIH Clinical Trials Database
- NLM MEDLINEplus Health Information
- Product Approvals
- Product Labeling
- Product Shortages
- Recalls / Withdrawals / Field Corrections
- Safety Information
- Vaccines Provide Effective Protection
- Violative Advertising & Promotional Labeling Letters
- Warning Letters
- Other Compliance Actions
- FDA Consumer / Healthcare Information
- FDA Consumer Magazine
Reading Room (EFOIA)
- Approval Information
- Blood Memos
- Code of Federal Regulations - Biologics Related
- Compliance Programs
- Compliance / Surveillance
- FDA Modernization Act (FDAMA)
- Guidances
- Healthcare Letters
- Information Sheets
- Meeting Minutes
- Medical Device User Fee & Modernization Act (MDUFMA)
- Notice of Initiation of Disqualification Proceedings and Opportunity to Explain (NIDPOE) Letters
- Postmarket Commitments
- Prescription Drug User Fee Act (PDUFA)
- Presentations / Summaries
- Product Shortages
- Recalls / Withdrawals / Field Corrections
- Rules
- Safety Information
- Talk Papers
- Transfer of Therapeutic Products to CDER
- Violative Advertising & Promotional Labeling Letters
- Warning Letters
- Other Compliance Actions
- Additional Documents Available From FDA
- Related Publications
Meetings and Workshops
- Advisory Committees
- Clinical Hold / Refusal to File Meetings
- FDAMA - Stakeholder
- Minutes / Transcripts
- Presentations / Summaries
- Workshops & Conferences
|
Blood
- Advisory Committees
- Blood Products
- Transmissible Spongiform Encephalopathies
- HHS Blood Safety
- Albumin Safety
- Blood Action Plan
- Blood Establishment Computer Software
- Blood Establishment Registration
- Blood Establishment Registration Public Query
- Bovine Spongiform Encephalopathy (BSE)
- Compliance Programs
- DIC following Rho(D) IGIV Administration
- Donor Screening / HIV
- Exceptions & Alternative Procedures Under 21CFR640.120
- Frequently Asked Questions
- Hemochromatosis Variances
- Keeping Blood Transfusions Safe
- Mercury in Plasma-Derived Products
- NIH Human Embryonic Stem Cell Registry
- Publications (Guidances, Rules, Info Sheets, Memoranda)
- SARS
- Transfusion Related Acute Lung Injury (TRALI)
- Varicella Zoster Immune Globulin (VZIG)
- West Nile Virus / Blood Safety
Vaccines
- Adverse Event Reporting System (VAERS)
- Advisory Committee
- Vaccines & Related Biological Products
- Anthrax
- Approval Process
- Bovine Spongiform Encephalopathy (BSE)
- Frequently Asked Questions
- Flu (Influenza) Vaccine
- Licensed / Distributed Vaccines
- Publications / Transcripts
- Smallpox
- Thimerosal
- Vaccines for Kids
- Vaccines Provide Effective Protection
- Vaccines and Autism
Cellular & Gene Therapy
- Advisory Committee
- Cellular, Tissue & Gene Therapies
- Cellular Therapy: Potential Treatment for Heart Disease
- Cloning Technology
- Gene Therapy Patient Tracking System
- Human Gene Therapy and the Role of the FDA
- New Human Gene Transfer Research Data System
- Publications
- Recombinant DNA and Gene Transfer, Office of Biotechnology Activities, NIH
- Type I Diabetes / Pancreatic Islet Transplantation
- Warning Letters
Tissue
- Adverse Reaction Reporting
- Advisory Committee
  - Cellular, Tissue & Gene Therapies
- Establishment Inspection Related Documents
- Exemptions and Alternative Procedures Under 21 CFR Part 1271.155
- HCT / P Deviation Reporting
- Meeting Information
- NIH Human Embryonic Stem Cell Registry
- Nucleic Acid Testing of Cadaveric Donors
- Publications
- Tissue Action Plan
- Tissue Reference Group
- Tissue Banks: Dangers of Tainted Tissue
- Tissue Registration
- Tissue Registration Public Query
- Tissue Related Product Approvals
- Xenotransplantation Action Plan
Devices
- Device Action Plan
- Devices Regulated by CBER
- Medical Device User Fee & Modernization Act (MDUFMA)
- Publications
- Application Submission Information
- Blood Establishment Computer Software
- Donor Screening / HIV
Allergenics
- Allergenic Products Advisory Committee
- Publications
Research
- Investigators
- Research Projects Search
- Research Opportunities
- FDA-NCI Clinical Proteomics Program
Countering Bioterrorism
- Anthrax
- Smallpox
- Frequently Asked Questions
- Bioterrorism Act of 2002
- Project BioShield Act of 2004
- Security Resource Sheet
- FDA, HHS, CDC Bioterrorism Information
|